Atlas Trials

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

Clinical trial NCT02742623 · COMPLETED

Trial details

NCT number
NCT02742623
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Venous Thrombosis and Pulmonary Embolism
Start date
2016-10-11
Primary completion
2018-11-30
Enrollment
528

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.